elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40048316-4EC9FC11-47AA-4922-8819-D2BA3581E752
Q40048316-4EC9FC11-47AA-4922-8819-D2BA3581E752
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40048316-4EC9FC11-47AA-4922-8819-D2BA3581E752
Open-label phase I clinical trial of Ad5-EBOV in Africans in China.
P2860
Q40048316-4EC9FC11-47AA-4922-8819-D2BA3581E752
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40048316-4EC9FC11-47AA-4922-8819-D2BA3581E752
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ad60ed9216ed54e42685981283333ba747b3aa7b
P2860
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.